gastroesophageal cancer
Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing
The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.
Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors
Palmetto has expanded the local coverage determination for the Guardant360 liquid biopsy assay to be used with the majority of advanced solid tumors.
FDA Approves Expanded Use of Agilent CDx for Keytruda in Lung Cancer
The diagnostic can now be used to identify a wider range of patients with stage III or metastatic NSCLC who may benefit from first-line treatment with Keytruda.
Roche, Five Prime Therapeutics to Develop CDx Assays for Immuno-Oncology Drug Trials
Five Prime will use an IHC CDx to analyze the use of investigational drug candidates in patients with advanced gastric or gastroesophageal junction cancer.
PGDx to Develop Liquid Biopsy Companion Dx for Five Prime Therapeutics' Drug Candidate
The ctDNA assay will be used to select patients for Phase 3 of Five Prime's registrational trial investigating bemarituzumab in gastric cancer patients.